Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Descriptor ID |
D002471
|
| MeSH Number(s) |
C04.697.098.500 C23.550.727.098.500
|
| Concept/Terms |
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Transformation, Neoplastic Cell
- Neoplastic Cell Transformation
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
|
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 3 | 5 |
| 1995 | 1 | 3 | 4 |
| 1996 | 1 | 3 | 4 |
| 1997 | 3 | 2 | 5 |
| 1998 | 2 | 1 | 3 |
| 1999 | 0 | 5 | 5 |
| 2000 | 5 | 3 | 8 |
| 2001 | 0 | 3 | 3 |
| 2002 | 1 | 4 | 5 |
| 2003 | 2 | 6 | 8 |
| 2004 | 8 | 6 | 14 |
| 2005 | 5 | 8 | 13 |
| 2006 | 4 | 6 | 10 |
| 2007 | 9 | 8 | 17 |
| 2008 | 6 | 5 | 11 |
| 2009 | 5 | 8 | 13 |
| 2010 | 6 | 7 | 13 |
| 2011 | 8 | 5 | 13 |
| 2012 | 15 | 12 | 27 |
| 2013 | 9 | 10 | 19 |
| 2014 | 10 | 8 | 18 |
| 2015 | 12 | 7 | 19 |
| 2016 | 5 | 6 | 11 |
| 2017 | 5 | 4 | 9 |
| 2018 | 3 | 2 | 5 |
| 2019 | 6 | 2 | 8 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 3 | 4 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
MGA deletion leads to Richter's transformation by modulating mitochondrial OXPHOS. Sci Transl Med. 2024 Jul 31; 16(758):eadg7915.
-
Malignant progression of preleukemic disorders. Blood. 2024 05 30; 143(22):2245-2255.
-
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis. J Clin Invest. 2024 Apr 15; 134(8).
-
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review. Am J Clin Dermatol. 2024 May; 25(3):391-405.
-
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells. Int J Mol Sci. 2024 Jan 11; 25(2).
-
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers. Cancer Discov. 2023 06 02; 13(6):1478-1497.
-
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype. Gastroenterology. 2023 05; 164(6):921-936.e1.
-
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma. Cancer Lett. 2023 01 01; 552:215984.
-
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation. Blood Cancer Discov. 2022 09 06; 3(5):444-467.
-
Tcf-1 promotes genomic instability and T cell transformation in response to aberrant ß-catenin activation. Proc Natl Acad Sci U S A. 2022 08 09; 119(32):e2201493119.